Summary: Interference occurs between individuals when the treatment (or exposure) of one individual affects the outcome of another individual. Previous work on causal inference methods in the presence of interference has focused on the setting where a priori it is assumed there is 'partial interference,' in the sense that individuals can be partitioned into groups wherein there is no interference between individuals in different groups. Bowers, Fredrickson, and Panagopoulos (2012) and Bowers, Fredrickson, and Aronow (2016) consider randomization-based inferential methods that allow for more general interference structures in the context of randomized experiments. In this paper, extensions of Bowers et al. which allow for failure time outcomes subject to right censoring are proposed.
Introduction
Interference arises when an individual's potential outcomes depend on the treatment status of others. Assuming interference is absent when assessing the causal effect of a treatment on an outcome may be scientifically implausible in certain settings. For example, in the study of infectious diseases, whether one individual receives a vaccine may affect whether another individual becomes infected or develops the disease. Motivated by infectious diseases and other settings where individuals interact, many existing causal inference methods have been extended to allow for interference; see Halloran and Hudgens (2016) for a recent review.
Some previous work on causal inference methods in the presence of interference has assumed a priori that there is partial interference (Sobel, 2006) , that is, individuals can be partitioned into groups wherein there is no interference between individuals in different groups. In this paper we consider the more general setting where interference between any two individuals may be assumed. Recent approaches that allow for the presence of general interference when evaluating treatment effects include Bowers, Fredrickson, and Panagopoulos (2012) , Bowers, Fredrickson, and Aronow (2016) , Sussman and Airoldi (2017) and Athey, Eckles, and Imbens (2018) among others. In randomized experiments where the treatment assignment mechanism is known, Bowers, Fredrickson, and Panagopoulos (2012) (henceforth BFP) described how to carry out randomization-based (i.e., permutation or design-based) inference on parameters in causal models which allow for general interference.
For an assumed causal model, a randomization-based approach entails constructing confidence sets for the causal parameters by inverting a set of hypothesis tests. An appealing aspect of randomization-based inference (Rosenbaum, 2002 , Chapter 2) is that no assumption of random sampling from some hypothetical superpopulation is invoked. Another benefit is the resulting 100(1 − α)% confidence sets are exact, i.e., the probability the true causal parameters are contained in a confidence set is at least the nominal level 1 − α. Moreover, in settings where possible interference is a priori assumed to have a specified network structure, it is unreasonable to assume individual outcomes are independent, such that standard frequentist approaches are not justified; in contrast randomization-based methods that allow for possible general interference readily apply.
In this article, we propose extensions of Bowers et al. to the setting where the response of interest is a failure time, and only the censoring time is observed for a subset of individuals due to right censoring. The proposal to permit right censored observations entails adapting the method of Wang, Lagakos, and Gray (2010) for two sample survival comparisons in the presence of unequal censoring. The remainder of this article is as follows. In Section 2 notation is introduced, causal models are defined, and the randomization inferential procedure by Bowers et al. when there is no censoring is reviewed. In Section 3 the proposed extension allowing for right censored outcomes is presented, and the proposed method is assessed via simulation studies. In Section 4 the methods are utilized to assess the effects of cholera vaccination in an individually-randomized trial of n = 73, 000 women and children in Matlab, Bangladesh. A brief discussion is provided in Section 5.
General Interference and Causal Models

General Interference
Consider a finite population of n individuals randomly assigned to either treatment or control.
For each individual i = 1, . . . , n, let Z i = 1 if individual i is assigned treatment and Z i = 0 otherwise. The vector comprising all treatment assignments is denoted Z = (Z 1 , . . . , Z n ).
The uppercase Z denotes the random variable corresponding to treatment assignment and the lowercase z denotes possible realizations of Z. Let y i (z) denote the potential outcome for individual i that would be observed for treatment assignment z; the observed outcome is denoted by Y i = y i (Z). The potential outcomes y i (z) for i ∈ {1, . . . , n} and z ∈ {0, 1} n are considered fixed features of the finite population of n individuals.
Define the n × n interference matrix A with (i, j) entry A ij for i, j ∈ {1, . . . , n} as follows.
Let A ij = 0 for i = j. For i = j let A ij = 0 if it is assumed a priori individual j does not interfere with individual i; otherwise let A ij = 1. We emphasize that A ij = 0 implies it is assumed a priori y i (z) does not depend on z j , whereas A ij = 1 merely indicates the possibility that individual j may interfere with individual i, and does not necessarily imply y i (z) depends on z j . Indeed, one of our primary inferential goals is to determine whether such possible interference is present. The definition of A encodes the assumption that any spillover effects on individual i may emanate only from individuals j where A ij = 1, and not from those where A ij = 0. The exact relationship between y i (z) and z is specified using a causal model described in the next section. Let the interference set (i.e., neighbors) for individual i be the set of individuals j ∈ {1, . . . , n} \ i where A ij = 1. Denote the i-th row of A by the vector A i , and the size of the interference set by the scalar A i = n j=1 A ij . Under partial interference, individuals can be partitioned into groups or clusters wherein there is no interference between groups, in which case A can be expressed as a block-diagonal matrix with each block corresponding to a group. Under general interference, each individual is allowed to have their own possibly unique interference set, so that there is no restriction on the structure of A. Here and throughout it is assumed A is known and invariant to treatment.
Causal Models
A (counterfactual) causal model expresses the potential outcomes y i (z) as a parametric deterministic function of any treatment z. Following Bowers et al., we consider a class of causal models which entail the composition of two functions. In particular, assume y i (z) = h{y i (0)|F(z; θ, A)} for user-specified functions h and F, with y i (0) denoting the potential outcome under the uniformity trial (Rosenbaum, 2007) where no one receives treatment. The function F(z; θ, A) takes as its arguments the treatment vector z, causal parameter θ, and interference matrix A. The dependence of F(z; θ, A) on i is left implicit notationally as it is implied under the specified causal model. For notational simplicity we write F = F(z; θ), with the dependence on A implicit. The specification of F determines how an individual's potential outcomes differ across different treatments z and different values of the parameter θ, and includes, but is not limited to, how direct and spillover effects propagate. The link function h maps y i (0) to y i (z) in terms of a specified F; in particular, the uniformity trial potential outcomes can be determined from the observed data under a specified causal model
In general, h may be any one-to-one function.
In practice, prior beliefs or background knowledge may be used to inform the choice of F and h. For the remainder of this paper, we consider two specific causal models, defined in
(1) and (2) below, and assume h(a|b) = a exp(b), although the proposed methods are general and apply to other forms of F and h. Denote the number and proportion of individual i's neighbors assigned to treatment by T i = A i Z T and G i = T i /A i respectively; here A i = 0 implies T i = G i = 0. Note that T i and G i depend on Z, but this dependence is suppressed for notational convenience. Let:
Causal model (2) was proposed by BFP and restricts interference to those who did not receive treatment, with the direct (or individual) effect parametrized to be larger in magnitude than the spillover (or peer) effect. Under both causal models, the effect of treatment Z on the outcome for individual i takes the form of a bivariate treatment: Z i is the (individual) treatment received, and G i (or T i ) is the proportion (or number) of individuals in the interference set treated. The parameters δ and τ measure the extent to which the potential outcomes increase or decrease, relative to y i (0), due to Z i and G i (or T i ). As both G i and T i depend only on the total number in the interference set treated, a peer effect homogeneity assumption is implied by these two causal models; Hudgens and Halloran (2008) refer to the assumption as stratified interference. Causal models allowing for interference that does not occur via the summary T i can also be utilized within this framework. For example, we might posit F = δZ i + τ Z M i where M i = argmax j:A ij =1 A j denotes the neighbor of individual i having the biggest interference set. See Ogburn et al. (2017) and Sussman and Airoldi (2017) for other causal models that allow for interference. The next section describes how to carry out randomization inference for the parameter θ = (δ, τ ) under a specified F.
Randomization inference
For a specified causal model F, the uniformity trial potential outcomes under a null hypothesis H 0 : θ = θ 0 can be determined from the observed data by
a randomized experiment where individuals are assigned treatment with equal probability, the uniformity trial outcomes should be similarly distributed between treatment (Z = 1) and control (Z = 0) groups (Rosenbaum, 2002) if H 0 is true and F is correctly specified. Therefore the null hypothesis H 0 can be tested using a test statistic T S(Z; θ 0 ) that compares the uniformity outcomes between treated and untreated individuals. For example, BFP used the two-sample Kolmogorov-Smirnov (KS) test statistic to compare the empirical distributions of the uniformity outcomes in the treatment and control groups. Bowers, Fredrickson, and Aronow (2016) proposed a multiple linear regression model of the uniformity outcomes on Z and T , using the resulting sum of squares of residuals as a test statistic.
For a chosen test statistic T S(Z; θ 0 ), the plausibility of H 0 can be assessed by evaluating the frequency of obtaining a value at least as 'extreme' (from H 0 ) as the observed value, over hypothetical re-assignments of Z under H 0 . Here and throughout a completely randomized experiment is assumed, where the number assigned to treatment, denoted by
The sample space of all hypothetical re-assignments Z is the set of vectors of length n containing m 1's and n − m 0's, and is denoted by Ω = {z :
Assuming that H 0 is true, each re-assignment occurs with probability |Ω| −1 , so that a two-sided p-value may be defined as pv(θ 0 ) = |Ω| −1 z∈Ω I {T S(z; θ 0 ) T S(Z; θ 0 )}, where without loss of generality it is assumed the larger values of T S(Z; θ 0 ) suggest stronger evidence against H 0 , and I{B} = 1 if B is true and 0 otherwise. When it is not computationally feasible to enumerate Ω exactly, an approximation of Ω based on C random draws of z from Ω may be used to yield an approximate p-value, denoted by pv C (θ 0 ).
Confidence sets can be constructed by test inversion. In particular, the subset of θ 0 values where pv(θ 0 ), or pv C (θ 0 ), is greater than or equal to α forms a 100(1 − α)% exact confidence set for θ. Confidence sets for individual parameters in θ can be obtained readily from a confidence set for θ. For example, a 100(1 − α)% confidence set for δ is given by all values of δ 0 such that there exists some value of τ 0 where (δ 0 , τ 0 ) is in the (joint) 100(1 − α)% confidence set for (δ, τ ).
It is important to note that each hypothesis test assesses the compatibility of the observed data with the assumed causal model F and assumed parameter values θ 0 specified by F under the null. Rejection of the hypothesis only indicates that either F or θ 0 is implausible.
In some circumstances all feasible parameter values for an assumed causal model may be rejected, leading to an empty confidence set. This indicates all possible parameter values are implausible, implying that the assumed causal model provides a poor fit to the data.
Right censored failure time outcomes
Now suppose each individual's response is a (positive) failure time, subject to right censoring if the individual is not followed long enough for failure to be observed. For i = 1, . . . , n, letỸ i and C i denote the failure time and the censoring time respectively.Ỹ i is observed only ifỸ i C i , so that the observed data are Y i = min{Ỹ i , C i } and the failure indicator
Under a null hypothesis H 0 : θ = θ 0 for a specified causal model F, let 
comprising the uniformity trial potential outcomes and failure indicators respectively.
Test statistics that accommodate right censoring
The test statistics considered in Section 2.3 require modification to accommodate right censoring. Instead of the KS statistic, the log-rank (LogR) statistic may be used to compare the right censored uniformity failure times in the treatment and control groups. An analog of the multiple linear regression model is the parametric accelerated failure time (AFT) model where the log-transformed failure times are linear functions of the predictors. In the following we consider a log-normal AFT model of the uniformity failure times given by Note the AFT model should only be considered as a 'working model,' used solely to generate a test statistic for a hypothesis testing procedure. Under the randomization-based framework, valid inference does not rely on this working model being correctly specified.
Rather,l(Z, D; θ 0 ) can simply be viewed as a mathematical (scalar) summary of {y (0), D, Z} that is compared against other treatment assignments for assessing the plausibility of the null hypothesis H 0 : θ = θ 0 .
Empirical size of tests with right censoring
The randomization-based inferential procedures described in Section 2. Step 0. The uniformity failure times were generated as logỹ i (0) ∼ N (µ, σ 2 ), where (µ, σ) = (4.5, 0.25).
Step 1. The observed treatment assignment Z was randomly drawn from Ω. The failure time for individual i with observed treatment (Z i , G i ) was determined byỸ i =
The values of (δ † , τ † ) were chosen so that for G i > 0.25, the magnitude of the spillover effect was greater than the direct effect, i.e., τ
The censoring times were then drawn from distributions that depended on treatment. First the dropout timesC i were randomly drawn from
The administrative censoring time was defined as C i = exp(µ + 2σ + τ † ). If Z i = 1, the censoring time was set to C i = min{C i ,C i }; otherwise, it was assumed there was no dropout and C i = kC i for some specified proportion k. The observed outcomes Y i and failure indictors D i
were determined as defined above.
Step 2. Under H 0 : (δ 0 , τ 0 ) = (0.7, 2.8), the uniformity outcomes were determined by y i (0) =
For the dataset {y(0), D, Z}, the LogR and LRaft tests were carried out, holding D fixed over re-assignments. The p-values pv C (δ 0 , τ 0 ) were calculated with C = 10000.
Step 0 was carried out once, then steps 1 and 2 repeated 5000 times each for k = 1, m = 124.
The empirical cumulative distribution functions (ECDFs) of the LogR and LRaft p-values are plotted in the left panel of Figure 1 . Neither test controlled the nominal type I error rate in general, with both ECDFs above the diagonal indicating inflated rejection rates of H 0 above the nominal size. While the empirical type I error rate of the LogR test was below the nominal rate at certain significance levels, this is not guaranteed to be the case in general.
[ Returning to the setting where there is interference, in Section 3.2 the null hypothesis H 0 : θ = θ 0 for a specified causal model was tested by conducting a randomization test of no effect of treatment on the uniformity trial potential outcomes y(0) for assumed θ 0 , with each test statistic a function of {y (0), D, Z}. Unfortunately, the standard randomization testing approach described above cannot be used to determine a test statistic's sampling distribution under the null because in general an individual's censoring indicator D i will not be fixed over all possible re-assignments z ∈ Ω and all possible values of θ 0 to be tested, even if treatment has no effect on the censoring times. To see this, consider the causal model F add and suppose 
i.e., individual i would not be censored for re-assignment z . Thus it is not surprising that the empirical results in the previous section demonstrate that the randomization tests as presented do not in general have type I error rates close to the nominal level. Instead, we propose the following randomization-based method that allows for the set of censored individuals to vary over randomizations. The proposed procedure entails adapting the IP Z permutation test by Wang et al. (2010) . Given observed data {Y, D, Z}, the following steps are carried out to test H 0 : (δ, τ ) = (δ 0 , τ 0 ):
e.g., under the causal model
Calculate the observed value of the chosen test statistic, e.g., the log-rank statistic, using {y(0), D, Z}. 7. The sampling distribution of the chosen test statistic can be obtained by repeating steps 2 to 6. The p-value for testing H 0 can be determined by comparing the resulting sampling distribution with the observed value from step 1.
Empirical evaluation of proposed tests
The simulation study in Section 3.2 was repeated, but with step 2 replaced by the proposed method in Section 3. In summary, results from these simulation studies indicate the randomization test procedure in Section 3.3 controls the type I error (empirically) over a range of settings, and the LRaft test tends to be as or more powerful than the LogR test. Moreover, the LogR test can lack power to detect spillover effects and thus is not recommended in practice when assuming the additive causal model.
[ Figure 2 about here.]
Application to randomized trial of cholera vaccine
In this section the methods described above are utilized to assess the effects of cholera were right censored either due to outmigration from the field trial area or death prior to the end of the study, or administrative censoring at the end of the study on June 1, 1986.
Interference specifications
The vaccine trial is analyzed using one of three different specifications of interference in turn. Person-to-person transmission of cholera often takes place within the same bari, i.e., [ Figure 3 about here.]
The study population also included 44887 individuals who did not participate in the randomized trial, and thus have zero probability of receiving either cholera vaccine. However, most of these individuals also resided in the same baris as those who took part in the trial: 5661 baris contained a mixture of participants and non-participants, with a median participation rate of 71% within a bari. Since the three specified interference sets are defined based on baris, the definition of G i is expanded to include non-trial participants as follows. There is evidence vaccination has an effect on the risk of cholera as the 95% confidence sets exclude (δ, τ ) = (0, 0) under all three interference specifications. Point estimates of the joint treatment effects, corresponding to values of (δ 0 , τ 0 ) with the largest p-value, are positive, suggesting the effect of the vaccine in reducing the risk of cholera is a combination of protective direct and spillover effects. The direct effect estimates are similar across the three interference specifications, whereas the spillover effect estimate is somewhat higher for the Social interference specification. For the 500m interference structure, the estimated treatment effect is (δ,τ ) = (0.7, 4.0). We offer two interpretations of (δ,τ ) under the additive causal model. First, the average time until cholera diagnosis had everyone not received vaccine (i.e., the uniformity trial) is estimated to be exp(0.7 + 4.0) = exp(4.7) ≈ 110 times faster than if everyone had received vaccine (e.g., the 'blanket coverage' trial). Second, the estimated risk of cholera incidence at 365 days under the uniformity trial would be approximately 2.30% compared to 0.06% under the blanket coverage trial, corresponding to a 98% reduction.
The individual parameter estimates also have a straightforward interpretation. For example, holding the proportion of neighbors treated fixed, exp(δ) = exp(0.7) ≈ 2 is the estimated ratio of survival times when an individual receives treatment versus control. Similarly, holding individual treatment fixed, exp(τ ) = exp(4.0) ≈ 55 is the estimated ratio of survival times when all neighbors are treated compared to no neighbors being treated.
The BFP model was considered unrealistic a priori for this example because there was no plausible scientific rationale for assuming the spillover effect to be strictly smaller in magnitude than the direct effect and to be limited to those who do not receive the vaccine.
Nonetheless, for the sake of completeness, inference was carried out for parameters under an assumed BFP model. There were no p-values that were above 0.05, suggesting that the BFP model is a poor fit to the data.
Discussion
In this paper we proposed randomization-based methods for assessing the effect of treatment on right-censored outcomes in the presence of general interference. There are several avenues of possible future research related to the methods for censored outcomes developed in this paper. The adapted IP Z procedure as implemented only allows for unequal censoring based on Z. To allow for censoring to differ based on both Z and G, a stratified Cox proportional hazards model, with Z and G as strata and predictor respectively, may be used in place of the KM estimator of the censoring distributions. Since inference is contingent on the choice of interference structure assumed, possible extensions include developing sensitivity analysis methods for assessing robustness to interference structure misspecification. Alternatively, extensions of randomization-based inference approaches that do not require a parametric causal model, such as Sävje et al. (2017) , to the setting where outcomes are censored could be considered. Methods such as Athey et al. (2018) and Jagadeesan et al. (2017) that use restricted randomizations to improve statistical power and computational speed might be considered in future work. While illustrated in this paper using data from an individually-randomized trial, the proposed methods can be employed in cluster-randomized trials. Finally, although this paper has focused on two specific causal models, the proposed methods are general and easily extended to other causal models. The simulation study was also carried out using a (symmetric) interference structure that was generated as a linear preferential attachment (PA) network following Section 9.2 of Jagadeesan et al. (2017) . The network is constructed by starting with a single individual and then adding one new individual at a time until there are n individuals in the network.
Each new individual that is added, denoted by e.g., j, forms an edge with each of the existing individuals i = 1, . . . , j − 1 with a probability that is proportional to A i ; for j m, each new individual j that is added forms m new edges. The network can be generated using the sample pa function in the igraph package (Csardi and Nepusz, 2006) . As in the simulation study in Section 3.2, the average number of neighbors is about 16; however, there are now individuals with comparatively large number of neighbors e.g., about 70. This simulation Figure 9 . Empirical cumulative distributions of p-values from a simulation study using the proposed method in Section 3.3. The true parameter values used to generate the data were (δ, τ ) = (0.7, 2.8). The assumed values of (δ 0 , τ 0 ) for testing the null hypothesis are stated in the title of each panel. . Average empirical coverage of LRaft (left) and LogR (right) 95% confidence sets. Each value of (δ 0 , τ 0 ) tested is indicated by a square, with the empirical coverage determined by the proportion of 95% confidence sets that included each pair of (δ 0 , τ 0 ). The contours are labelled with the coverage levels, with filled squares indicating coverage of at least 0.95. The true parameter values used to generate the data were (δ, τ ) = (0.7, 2.8). Figure 11 . Interference matrices for all n = 72965 participants in the randomized cholera vaccine trial, based on Neighborhood (left), 500m (center), and Social (right) interference specifications.
